Candel Therapeutics, Inc. (CADL)
NASDAQ: CADL · Real-Time Price · USD
5.04
+0.91 (21.89%)
At close: Nov 22, 2024, 4:00 PM
5.12
+0.08 (1.59%)
After-hours: Nov 22, 2024, 7:56 PM EST
Candel Therapeutics Market Cap
Candel Therapeutics has a market cap or net worth of $163.68 million as of November 22, 2024. Its market cap has increased by 465.97% in one year.
Market Cap
163.68M
Enterprise Value
163.14M
1-Year Change
465.97%
Ranking
Category
Stock Price
$5.04
Market Cap Chart
Since the IPO on July 27, 2021, Candel Therapeutics's market cap has decreased from $222.39M to $163.68M, a decrease of -26.40%. That is a compound annual growth rate of -8.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 21, 2024 | 134.29M | 215.88% |
| Dec 29, 2023 | 42.51M | -17.80% |
| Dec 30, 2022 | 51.72M | -76.95% |
| Dec 31, 2021 | 224.35M | 0.88% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pro-Dex | 137.97M |
| Black Diamond Therapeutics | 137.50M |
| Vaxart | 136.30M |
| TriSalus Life Sciences | 135.08M |
| Inhibikase Therapeutics | 135.06M |
| Telomir Pharmaceuticals | 132.36M |
| Compugen | 129.83M |
| Innate Pharma | 129.75M |